DBV Technologies To Conduct New Pivotal Trial For Peanut Allergy Patch, Shares Plunge To 52-Week Low<blockquote>DBV Technologies将对花生过敏贴剂进行新的关键试验,股价暴跌至52周低点</blockquote>
Vir Biotechnology continued to gain over 7% in morning trading after showing neutralizing activity against omicron<blockquote>Vir Biotechnology在显示出对奥密克戎的中和活性后,早盘继续上涨超过7%</blockquote>